Report Detail

Pharma & Healthcare Global Gene Therapy Drugs Market Size, Status and Forecast 2020-2026

  • RnM4271911
  • |
  • 27 December, 2020
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Gene Therapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Neuromuscular Disease
    • 1.3.3 Genetic Disease
    • 1.3.4 Other
  • 1.4 Market by Application
    • 1.4.1 Global Gene Therapy Drugs Market Share by Application: 2020 VS 2026
    • 1.4.2 Hospital
    • 1.4.3 Pharmacy
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Gene Therapy Drugs Market Perspective (2015-2026)
  • 2.2 Gene Therapy Drugs Growth Trends by Regions
    • 2.2.1 Gene Therapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gene Therapy Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gene Therapy Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Gene Therapy Drugs Industry Dynamic
    • 2.3.1 Gene Therapy Drugs Market Trends
    • 2.3.2 Gene Therapy Drugs Market Drivers
    • 2.3.3 Gene Therapy Drugs Market Challenges
    • 2.3.4 Gene Therapy Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene Therapy Drugs Players by Market Size
    • 3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2015-2020)
  • 3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
  • 3.4 Global Gene Therapy Drugs Market Concentration Ratio
    • 3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2019
  • 3.5 Key Players Gene Therapy Drugs Area Served
  • 3.6 Key Players Gene Therapy Drugs Product Solution and Service
  • 3.7 Date of Enter into Gene Therapy Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy Drugs Breakdown Data by Type

  • 4.1 Global Gene Therapy Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2021-2026)

5 Gene Therapy Drugs Breakdown Data by Application

  • 5.1 Global Gene Therapy Drugs Historic Market Size by Application (2015-2020)
  • 5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gene Therapy Drugs Market Size (2015-2026)
  • 6.2 North America Gene Therapy Drugs Market Size by Type (2015-2020)
  • 6.3 North America Gene Therapy Drugs Market Size by Application (2015-2020)
  • 6.4 North America Gene Therapy Drugs Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Gene Therapy Drugs Market Size (2015-2026)
  • 7.2 Europe Gene Therapy Drugs Market Size by Type (2015-2020)
  • 7.3 Europe Gene Therapy Drugs Market Size by Application (2015-2020)
  • 7.4 Europe Gene Therapy Drugs Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Therapy Drugs Market Size (2015-2026)
  • 8.2 Asia-Pacific Gene Therapy Drugs Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Gene Therapy Drugs Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Gene Therapy Drugs Market Size (2015-2026)
  • 9.2 Latin America Gene Therapy Drugs Market Size by Type (2015-2020)
  • 9.3 Latin America Gene Therapy Drugs Market Size by Application (2015-2020)
  • 9.4 Latin America Gene Therapy Drugs Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Therapy Drugs Market Size (2015-2026)
  • 10.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Gene Therapy Drugs Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 F. Hoffmann-La Roche AG
    • 11.1.1 F. Hoffmann-La Roche AG Company Details
    • 11.1.2 F. Hoffmann-La Roche AG Business Overview
    • 11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
    • 11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2015-2020))
    • 11.1.5 F. Hoffmann-La Roche AG Recent Development
  • 11.2 Novartis International AG
    • 11.2.1 Novartis International AG Company Details
    • 11.2.2 Novartis International AG Business Overview
    • 11.2.3 Novartis International AG Gene Therapy Drugs Introduction
    • 11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.2.5 Novartis International AG Recent Development
  • 11.3 Gilead Sciences, Inc.
    • 11.3.1 Gilead Sciences, Inc. Company Details
    • 11.3.2 Gilead Sciences, Inc. Business Overview
    • 11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
    • 11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.3.5 Gilead Sciences, Inc. Recent Development
  • 11.4 Ultragenyx Pharmaceutical,Inc.
    • 11.4.1 Ultragenyx Pharmaceutical,Inc. Company Details
    • 11.4.2 Ultragenyx Pharmaceutical,Inc. Business Overview
    • 11.4.3 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Introduction
    • 11.4.4 Ultragenyx Pharmaceutical,Inc. Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.4.5 Ultragenyx Pharmaceutical,Inc. Recent Development
  • 11.5 Applied Genetic Technologies Corp
    • 11.5.1 Applied Genetic Technologies Corp Company Details
    • 11.5.2 Applied Genetic Technologies Corp Business Overview
    • 11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
    • 11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.5.5 Applied Genetic Technologies Corp Recent Development
  • 11.6 Audentes Therapeutics
    • 11.6.1 Audentes Therapeutics Company Details
    • 11.6.2 Audentes Therapeutics Business Overview
    • 11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
    • 11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.6.5 Audentes Therapeutics Recent Development
  • 11.7 BioMarin Pharmaceutical
    • 11.7.1 BioMarin Pharmaceutical Company Details
    • 11.7.2 BioMarin Pharmaceutical Business Overview
    • 11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
    • 11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.7.5 BioMarin Pharmaceutical Recent Development
  • 11.8 Bluebird Bio
    • 11.8.1 Bluebird Bio Company Details
    • 11.8.2 Bluebird Bio Business Overview
    • 11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
    • 11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.8.5 Bluebird Bio Recent Development
  • 11.9 Nightstar Therapeutics
    • 11.9.1 Nightstar Therapeutics Company Details
    • 11.9.2 Nightstar Therapeutics Business Overview
    • 11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
    • 11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.9.5 Nightstar Therapeutics Recent Development
  • 11.10 Sangamo Therapeutics
    • 11.10.1 Sangamo Therapeutics Company Details
    • 11.10.2 Sangamo Therapeutics Business Overview
    • 11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
    • 11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
    • 11.10.5 Sangamo Therapeutics Recent Development
  • 11.11 Spark Therapeutics
    • 10.11.1 Spark Therapeutics Company Details
    • 10.11.2 Spark Therapeutics Business Overview
    • 10.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
    • 10.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
    • 10.11.5 Spark Therapeutics Recent Development
  • 11.12 uniQure
    • 10.12.1 uniQure Company Details
    • 10.12.2 uniQure Business Overview
    • 10.12.3 uniQure Gene Therapy Drugs Introduction
    • 10.12.4 uniQure Revenue in Gene Therapy Drugs Business (2015-2020)
    • 10.12.5 uniQure Recent Development
  • 11.13 VBL Therapeutics
    • 10.13.1 VBL Therapeutics Company Details
    • 10.13.2 VBL Therapeutics Business Overview
    • 10.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
    • 10.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
    • 10.13.5 VBL Therapeutics Recent Development
  • 11.14 Voyager Therapeutics
    • 10.14.1 Voyager Therapeutics Company Details
    • 10.14.2 Voyager Therapeutics Business Overview
    • 10.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
    • 10.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2015-2020)
    • 10.14.5 Voyager Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Gene Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Neuromuscular Disease
    Genetic Disease
    Other

    Market segment by Application, split into
    Hospital
    Pharmacy

    Based on regional and country-level analysis, the Gene Therapy Drugs market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapy Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    F. Hoffmann-La Roche AG
    Novartis International AG
    Gilead Sciences, Inc.
    Ultragenyx Pharmaceutical,Inc.
    Applied Genetic Technologies Corp
    Audentes Therapeutics
    BioMarin Pharmaceutical
    Bluebird Bio
    Nightstar Therapeutics
    Sangamo Therapeutics
    Spark Therapeutics
    uniQure
    VBL Therapeutics


    Summary:
    Get latest Market Research Reports on Gene Therapy Drugs. Industry analysis & Market Report on Gene Therapy Drugs is a syndicated market report, published as Global Gene Therapy Drugs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Gene Therapy Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,852.36
    4,278.54
    5,704.73
    3,206.62
    4,809.92
    6,413.23
    405,486.90
    608,230.35
    810,973.80
    285,191.01
    427,786.52
    570,382.02
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report